Literature DB >> 22854434

Atrial fibrillation: new drugs, devices, and procedures.

Bruce D Lindsay1.   

Abstract

The way atrial fibrillation is managed has changed in recent years. Although new anticoagulants are available and more are coming, they offer only marginal benefit over warfarin (Coumadin) and have the disadvantages that their levels cannot be monitored and that their effect cannot be reversed rapidly if bleeding develops. Attempts should be made To Whom It May Concern: control symptomatic atrial fibrillation, first with antiarrhythmic drugs, then with radiofrequency ablation or with a combination. Ablation can be repeated for fibrillation that persists after the first few months.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854434     DOI: 10.3949/ccjm.79gr.12004

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  2 in total

Review 1.  Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management.

Authors:  Giovanni Peretto; Alessandro Durante; Luca Rosario Limite; Domenico Cianflone
Journal:  Cardiol Res Pract       Date:  2014-01-06       Impact factor: 1.866

2.  Rhythm Disturbance After Myocardial Revascularization.

Authors:  Nedzad Kadric; Enes Osmanovic
Journal:  Med Arch       Date:  2017-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.